IOVA

#1715
Iovance Biotherapeutics, Inc. - Common Stock
4.1 0 USD
-4.43%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
4.10
4.10
Year Range
1.66
5.63
Daily Change
-4.43%
Monthly Change
+22.75%
6 month change
+69.42%
Year Change
+125.27%
Previous Close
4.2 9
Open
4.1 0
Low
4.1 0
High
4.1 0
Volume
112
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 1.83 B
  • Employee 975
  • Founded 2007
  • CEO N/A
  • Website www.iovance.com
  • Headquarter Delaware, United States
  • FIGI BBG000FTLBV7
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.5
Price to sales ratio
0

Iovance Biotherapeutics, Inc. - Common Stock

Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer.

News